BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 33772746)

  • 1. Assessing potential impact of 2015 American Thyroid Association guidelines on community standard practice for I-131 treatment of low-risk differentiated thyroid cancer: case study of Jordan.
    Juweid ME; Rabadi NJ; Tulchinsky M; Aloqaily M; Al-Momani A; Arabiat M; Abu Ain G; Al Hawari H; Al-Momani M; Mismar A; Abulaban A; Taha I; Alhouri A; Zayed A; Albsoul N; Al-Abbadi MA
    Endocrine; 2021 Sep; 73(3):633-640. PubMed ID: 33772746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient Age Is an Independent Risk Factor of Relapse of Differentiated Thyroid Carcinoma and Improves the Performance of the American Thyroid Association Stratification System.
    Trimboli P; Piccardo A; Signore A; Valabrega S; Barnabei A; Santolamazza G; Di Paolo A; Stati V; Chiefari A; Vottari S; Simmaco M; Ferrarazzo G; Ceriani L; Appetecchia M; Giovanella L
    Thyroid; 2020 May; 30(5):713-719. PubMed ID: 31973653
    [No Abstract]   [Full Text] [Related]  

  • 3. Are Evidence-Based Guidelines Reflected in Clinical Practice? An Analysis of Prospectively Collected Data of the Italian Thyroid Cancer Observatory.
    Lamartina L; Durante C; Lucisano G; Grani G; Bellantone R; Lombardi CP; Pontecorvi A; Arvat E; Felicetti F; Zatelli MC; Rossi R; Puxeddu E; Morelli S; Torlontano M; Crocetti U; Montesano T; Giubbini R; Orlandi F; Aimaretti G; Monzani F; Attard M; Francese C; Antonelli A; Limone P; Rossetto R; Fugazzola L; Meringolo D; Bruno R; Tumino S; Ceresini G; Centanni M; Monti S; Salvatore D; Spiazzi G; Mian C; Persani L; Barbaro D; Nicolucci A; Filetti S
    Thyroid; 2017 Dec; 27(12):1490-1497. PubMed ID: 29020892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Prospective Implementation of the 2015 ATA Guidelines and Modified ATA Recurrence Risk Stratification System for Treatment of Differentiated Thyroid Cancer in a Canadian Tertiary Care Referral Setting.
    Wu J; Hu XY; Ghaznavi S; Kinnear S; Symonds CJ; Grundy P; Parkins VM; Sharma P; Lamb D; Khalil M; Hyrcza M; Chandarana SP; Pasieka JL; Harvey A; Warshawski J; Hart R; Deutschman M; Randall DR; Paschke R
    Thyroid; 2022 Dec; 32(12):1509-1518. PubMed ID: 36226405
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment outcomes in pediatric differentiated thyroid carcinoma.
    Bhavani N; Bhadran K; Nair V; Menon UV; Pavithran PV; Menon AS; Abraham N; Pankaj A; Kumar H
    J Pediatr Endocrinol Metab; 2018 Oct; 31(10):1117-1122. PubMed ID: 30157034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Stratification of Pediatric Patients with Differentiated Thyroid Cancer: Is Total Thyroidectomy Necessary for Patients at Any Risk?
    Sugino K; Nagahama M; Kitagawa W; Ohkuwa K; Uruno T; Matsuzu K; Suzuki A; Tomoda C; Hames KY; Akaishi J; Masaki C; Ito K
    Thyroid; 2020 Apr; 30(4):548-556. PubMed ID: 31910105
    [No Abstract]   [Full Text] [Related]  

  • 7. Acknowledging gray areas: 2015 vs. 2009 American Thyroid Association differentiated thyroid cancer guidelines on ablating putatively low-intermediate-risk patients.
    Frangos S; Iakovou IP; Marlowe RJ; Eftychiou N; Patsali L; Vanezi A; Savva A; Mpalaris V; Giannoula EI
    Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):185-189. PubMed ID: 27557846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the 2015 American Thyroid Association Risk Stratification System in High-Risk Papillary and Follicular Thyroid Cancer Patients.
    van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
    Thyroid; 2019 Aug; 29(8):1073-1079. PubMed ID: 31140385
    [No Abstract]   [Full Text] [Related]  

  • 9. Age, thyroglobulin levels and ATA risk stratification predict 10-year survival rate of differentiated thyroid cancer patients.
    Kelly A; Barres B; Kwiatkowski F; Batisse-Lignier M; Aubert B; Valla C; Somda F; Cachin F; Tauveron I; Maqdasy S
    PLoS One; 2019; 14(8):e0221298. PubMed ID: 31425569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible delayed diagnosis and treatment of metastatic differentiated thyroid cancer by adopting the 2015 ATA guidelines.
    Albano D; Bertagna F; Bonacina M; Durmo R; Cerudelli E; Gazzilli M; Panarotto MB; Formenti AM; Mazziotti G; Giustina A; Giubbini R
    Eur J Endocrinol; 2018 Sep; 179(3):143-151. PubMed ID: 29899030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of ATA Low-Risk Pediatric Thyroid Cancer Patients Not Treated With Radioactive Iodine Therapy.
    Bojarsky M; Baran JA; Halada S; Isaza A; Zhuang H; States L; Grant FD; Robbins S; Sisko L; Ricarte-Filho JC; Kazahaya K; Adzick NS; Mostoufi-Moab S; Bauer AJ
    J Clin Endocrinol Metab; 2023 Nov; 108(12):3338-3344. PubMed ID: 37265226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concordance in postsurgical radioactive iodine therapy recommendations between Watson for Oncology and clinical practice in patients with differentiated thyroid carcinoma.
    Kim M; Kim BH; Kim JM; Kim EH; Kim K; Pak K; Jeon YK; Kim SS; Park H; Kang T; Lee BJ; Kim IJ
    Cancer; 2019 Aug; 125(16):2803-2809. PubMed ID: 31216369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioactive iodine ablation post differentiated thyroid cancer surgery: an analysis of use and impact of the American Thyroid Association guidelines.
    Sia Y; Dave RV; Nour D; Miller JA; Skandarajah AR; Tasevski R
    ANZ J Surg; 2019 Nov; 89(11):E502-E506. PubMed ID: 31674140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-World Performance of the American Thyroid Association Risk Estimates in Predicting 1-Year Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study of 2000 Patients.
    Grani G; Zatelli MC; Alfò M; Montesano T; Torlontano M; Morelli S; Deandrea M; Antonelli A; Francese C; Ceresini G; Orlandi F; Maniglia CA; Bruno R; Monti S; Santaguida MG; Repaci A; Tallini G; Fugazzola L; Monzani F; Giubbini R; Rossetto R; Mian C; Crescenzi A; Tumino D; Pagano L; Pezzullo L; Lombardi CP; Arvat E; Petrone L; Castagna MG; Spiazzi G; Salvatore D; Meringolo D; Solaroli E; Monari F; Magri F; Triggiani V; Castello R; Piazza C; Rossi R; Ferraro Petrillo U; Filetti S; Durante C
    Thyroid; 2021 Feb; 31(2):264-271. PubMed ID: 32475305
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessment of the impact of 2015 American Thyroid Association guidelines in management of differentiated thyroid cancer patients.
    Choudhury S; Agrawal A; Pantvaidya G; Shah S; Purandare N; Puranik A; Rangarajan V
    Eur J Nucl Med Mol Imaging; 2020 Mar; 47(3):547-553. PubMed ID: 31707429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between the different doses of radioactive iodine ablation prescribed in patients with intermediate-to-high-risk differentiated thyroid cancer.
    Iizuka Y; Katagiri T; Ogura K; Mizowaki T
    Ann Nucl Med; 2019 Jul; 33(7):495-501. PubMed ID: 30955202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of low versus high radioiodine administered activity in patients with low-risk differentiated thyroid cancer.
    Ben Ghachem T; Yeddes I; Meddeb I; Bahloul A; Mhiri A; Slim I; Ben Slimene MF
    Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):655-660. PubMed ID: 27225282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European Perspective on 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: Proceedings of an Interactive International Symposium.
    Luster M; Aktolun C; Amendoeira I; Barczyński M; Bible KC; Duntas LH; Elisei R; Handkiewicz-Junak D; Hoffmann M; Jarząb B; Leenhardt L; Musholt TJ; Newbold K; Nixon IJ; Smit J; Sobrinho-Simões M; Sosa JA; Tuttle RM; Verburg FA; Wartofsky L; Führer D
    Thyroid; 2019 Jan; 29(1):7-26. PubMed ID: 30484394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of second primary malignancy is increased in differentiated thyroid cancer patients with a cumulative (131)I dose over 37 GBq.
    Khang AR; Cho SW; Choi HS; Ahn HY; Yoo WS; Kim KW; Kang KW; Yi KH; Park DJ; Lee DS; Chung JK; Cho BY; Park YJ
    Clin Endocrinol (Oxf); 2015 Jul; 83(1):117-23. PubMed ID: 25115234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of postoperative stimulated thyroglobulin level at the time of 131I ablation therapy for differentiated thyroid cancer.
    Hasbek Z; Turgut B; Kilicli F; Altuntas EE; Yucel B
    Asian Pac J Cancer Prev; 2014; 15(6):2523-7. PubMed ID: 24761858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.